BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Clinical Outcome
296 results:

  • 1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
    Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
    Xiong JX; Li YT; Tan XY; Chen T; Liu BH; Fu L
    Acta Pharmacol Sin; 2024 Feb; 45(2):405-421. PubMed ID: 37814123
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
    Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
    PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparing effectiveness and safety of paclitaxel plus raltitrexed
    Zhao X; Chen Z; Zhang X; Zhu X; Zhang W; Qiu L; Wang C; Huang M; Zhang Z; Li W; Yang L; Guo W
    Cancer Biol Med; 2023 Aug; 20(9):682-8. PubMed ID: 37653589
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PYloroplasty versus No Intervention in gastric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trial.
    Okada N; Kinoshita Y; Nishihara S; Kurotaki T; Sato A; Kimura K; Kushiya H; Umemoto K; Furukawa S; Yamabuki T; Takada M; Kato K; Ambo Y; Nakamura F
    Trials; 2023 Jun; 24(1):412. PubMed ID: 37337238
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
    Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
    BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer.
    Yang J; Li J; Deng Q; Chen Z; He K; Chen Y; Fu Z
    BMC Cancer; 2023 Mar; 23(1):246. PubMed ID: 36918834
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
    Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
    [No Abstract]    [Full Text] [Related]  

  • 9. Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
    Huemer F; Hecht S; Scharinger B; Schlintl V; Rinnerthaler G; Schlick K; Heregger R; Melchardt T; Wimmer A; Mühlbacher I; Koch OO; Neureiter D; Klieser E; Seyedinia S; Beheshti M; Greil R; Weiss L
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3051-3064. PubMed ID: 35864270
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.
    Chen QY; Zhou WJ; Zhang JG; Zhang X; Han QY; Lin A; Yan WH
    Int Immunopharmacol; 2022 Aug; 109():108798. PubMed ID: 35569305
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.
    Yang H; Hu Y; Weng M; Liu X; Wan P; Hu Y; Ma M; Zhang Y; Xia H; Lv K
    J Adv Res; 2022 Mar; 37():91-106. PubMed ID: 35499052
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of NOTCH1 and OCT4 in gastric carcinoma.
    Ibrahim DA; Elsebai EA; Fayed A; Abdelrahman AE
    Indian J Pathol Microbiol; 2022; 65(2):328-335. PubMed ID: 35435367
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Low clarithromycin resistance in virulent Helicobacter pylori from dyspeptic patients at a tertiary care centre in Odisha.
    Hallur V; Panigrahi M; Sable M; Ghosh M; Mohanty S; Purkait S; Praharaj A
    Indian J Med Microbiol; 2022; 40(2):211-216. PubMed ID: 35346525
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. clinical outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
    Fujii H; Iwaki M; Hayashi H; Toyoda H; Oeda S; Hyogo H; Kawanaka M; Morishita A; Munekage K; Kawata K; Yamamura S; Sawada K; Maeshiro T; Tobita H; Yoshida Y; Naito M; Araki A; Arakaki S; Kawaguchi T; Noritake H; Ono M; Masaki T; Yasuda S; Tomita E; Yoneda M; Kawada N; Tokushige A; Kamada Y; Takahashi H; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):370-379. PubMed ID: 35051649
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of preoperative CT angiography examination on the clinical outcome of patients with BMI ≥ 25.0 kg/m
    Meng C; Cao S; Liu X; Li L; He Q; Xia L; Jiang L; Chu X; Wang X; Wang H; Hui X; Sun Z; Huang S; Duan Q; Yang D; Zhang H; Tian Y; Li Z; Zhou Y
    Trials; 2021 Dec; 22(1):912. PubMed ID: 34895320
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Distribution, phenotype, functional and clinical relevance of CD8
    Shen Y; Li XL; Li YX; Shan ZG; Zhao YL; Cheng P; Zhao Z; Zhang JY; Chen W; Zhuang Y; Ma DY; Zou QM; Qiu Y; Peng LS
    Cancer Immunol Immunother; 2022 Jul; 71(7):1645-1654. PubMed ID: 34767045
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer.
    You Y; Hu S
    Cancer Biomark; 2022; 34(1):55-66. PubMed ID: 34657878
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.
    van Doorn L; Heersche N; de Man FM; de Bruijn P; Bijl I; Oomen-de Hoop E; Eskens FALM; van der Gaast A; Mathijssen RHJ; Bins S
    Clin Pharmacol Ther; 2022 Feb; 111(2):455-460. PubMed ID: 34656072
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. clinical outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of gastric cancer.
    Sindayigaya R; Dogan C; Demtröder CR; Fischer B; Karam E; Buggisch JR; Tempfer CB; Lecomte T; Ouaissi M; Giger-Pabst U
    Ann Surg Oncol; 2022 Jan; 29(1):112-123. PubMed ID: 34611790
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Fragmentation Analysis of Plasma DNA Reveals Its Prognostic Value in gastric cancer.
    Yoruker EE; Ozgur E; Keskin M; Ozgur I; Gezer U
    Turk J Gastroenterol; 2021 Sep; 32(9):720-726. PubMed ID: 34609300
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.